Name

PELF

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for PELF

Name

Alternate Names

4'-Epiadriamycin Hydrochloride
4'-Epidoxorubicin
4-EA
Ellence
Epidoxorubicin
Epidoxorubicin Hydrochloride
Epirubicin Hydrochloride
IMI-28
Pharmorubicin
Pidorubicin Hydrochloride

Abbreviations

EPI
epi-ADR

Category

Chemotherapy

Subcategory

Anthracycline
Antitumor antibiotic

NSC Number

256942

Primary Site

Breast cancer
Metastatic breast cancer
Gastric cancer

Histology

None

Remarks

Coding

This drug should be coded

Name

Alternate Names

5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596

Abbreviations

5-FU
5FU
FU

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

019893
19893

Primary Site

Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Head and Neck cancer
Hepatoma
Ovarian cancer
Skin-Basal cell carcinoma (topical application)

Histology

None

Remarks

Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.

Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum

Abbreviations

CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

119875

Primary Site

Bladder
ovarian
testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Alternate Names

Calcium folinate
Calcium leucovorin
Calcium leucovorin rescue
Citrovorum Factor
Citrovorum factor rescue
Folic acid
Folinic Acid
Lederfoline
Leucosar
Leucovorin Calcium
Leucovorin rescue
Wellcovorin

Abbreviations

C.F.
CF
CL

Category

Ancillary Agent

Subcategory

None

NSC Number

3590
003590

Primary Site

None

Histology

None

Remarks

The pharmacologically active form of folic acid. FDA approved uses as 1st line colorectal carcinoma in combination with 5-FU and to diminish methotrexate toxicity.

Coding

This drug should NOT be coded

Name

Alternate Names

G-CSF
GCSF
Neupogen
Zarxio
r-G-CSF
r-met Hu G-CSF
rhG-CSF

Abbreviations

None

Category

Ancillary Agent

Subcategory

None

NSC Number

614371
614629

Primary Site

None

Histology

None

Remarks

A granulocyte colony-stimulating factor (G-CSF). Adjunct of Ganciclovir therapy; treatment of neutropenia

March 2015: Zarxio is the first biosimilar product approved in the United States. A biosimilar product is a biological product that is based on a showing that it is highly similar to an already-approved biological product, known as a reference product. There are no differences in terms of safety and effectiveness from the reference product (neupogen)

Coding

This drug should NOT be coded
Glossary